A study of plasma cytokine levels in MDS patients found that increased levels of IL-6, chemokine (C-X-C motif) ligand 10 (CXCL10), and Interleukin 7 (IL-7) predict shorter overall survival independent of cytopenias. The gene discussed is IL7; the disease is myelodysplastic syndrome.